Captrust Financial Advisors Aerie Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$4.95 - $9.16 $331 - $613	-67 Reduced 13.32%	436 $3,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $2,836 - $4,929	503 New	503 $5,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $2,639 - $5,012	-376 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $5,700 - $7,132	376 New	376 $6,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.